$RGPX
REGENEREX PHARMA, INC. Stock $rgpx

2021 Q2 Form 10-Q Financial Statement

Concept	2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$5.954K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$869.0K
YoY Change
Total Liabilities & Shareholders Equity
YoY Change

Concept	2021 Q2
OPERATING ACTIVITIES
Net Income	-$33.95K
YoY Change
Depreciation, Depletion And Amortization	$497.00
YoY Change
Cash From Operating Activities	-$22.49K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$21.55K
YoY Change
NET CHANGE
Cash From Operating Activities	-$22.49K
Cash From Investing Activities
Cash From Financing Activities	$21.55K
Net Change In Cash	-$948.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities	-$22.49K
Capital Expenditures
Free Cash Flow
YoY Change

Frame	Concept Type	Concept / XBRL Key	Unit
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	USD
CY2021Q2	us-gaap	Gross Profit GrossProfit	USD
CY2021Q2	us-gaap	Revenues Revenues	USD
CY2021Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	USD
CY2020Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	USD
CY2021Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid	USD
CY2020Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid	USD
CY2021Q2	us-gaap	Interest Paid InterestPaid	USD
CY2020Q2	us-gaap	Interest Paid InterestPaid	USD
CY2020Q2	PEPT	Accrued Interest Converted Into Note Payable To Shareholder AccruedInterestConvertedIntoNotePayableToShareholder	USD